
Wave Life Sciences Ltd (WVE)
NASDAQ
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -58.837 | -61.389 | -66.75 | -53.208 | -50.281 | -91.582 | -27.3 | -30.936 |
Return on Equity (%) | -74.31 | -137.73 | -267.172 | -184.78 | -198.53 | 2570.047 | 2106.318 | -77.873 |
Return on Invested Capital (%) | -76.91 | -179.113 | -589.579 | -223.341 | -185.94 | 3955.474 | 2616.043 | -87.795 |
Operating Margin (%) | -2597.945 | -1016.956 | -1211.525 | -750.784 | -298.919 | -4416.059 | -51.357 | -89.572 |
Net Profit Margin (%) | -2619.574 | -1017.434 | -1211.525 | -746.675 | -298.421 | -4434.722 | -50.759 | -89.572 |
Book Value Per Share | 4.4 | 2.198 | 1.667 | 1.558 | 0.497 | -0.506 | 0.322 | 1.335 |
Earnings Per Share | -3.214 | -4.394 | -5.063 | -2.846 | -1.918 | -1.782 | -0.467 | -0.618 |
Cash Per Share | 4.491 | 5.238 | 3.848 | 3.502 | 2.362 | 0.974 | 1.628 | 1.925 |
Working Capital Per Share | 4.169 | 2.164 | 1.76 | 2.069 | 1.543 | 0.297 | 0.398 | 1.335 |
Operating Profit Per Share | 0.123 | 0.718 | 0.673 | 0.42 | 0.714 | 0.04 | 0.936 | 0.711 |
EBIT Per Share | -3.187 | -4.392 | -5.063 | -2.862 | -1.921 | -1.774 | -0.473 | -0.618 |
EBITDA Per Share | -3.187 | -4.392 | -5.063 | -2.862 | -1.921 | -1.774 | -0.473 | -0.618 |
Free Cash Flow Per Share | -2.619 | -4.097 | -5.202 | -3.246 | -2.063 | -1.878 | -0.533 | -0.667 |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 27.83M | 29.47M | 34.34M | 48.78M | 59.84M | 86.93M | 119.16M | 153.04M |
Year End December 30 2024 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 98.1M | 98.57M | 98.57M | 119.16M | 122.32M | 20.58M | 148.39M | 153.04M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -211.965 | N/A | N/A | N/A | -251.699 | N/A | N/A | N/A |
Net Profit Margin (%) | -211.965 | N/A | N/A | N/A | -251.699 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 1.47B |
Price to Earnings Ratio | -15.93 |
Price to Sales Ratio | 13.86 |
Price to Cash Ratio | 5.12 |
Price to Book Ratio | 7.38 |
Dividend Yield | - |
Shares Outstanding | 153.49M |
Average Volume (1 week) | 768.37k |
Average Volume (1 Month) | 1.14M |
52 Week Change | 69.53% |
52 Week High | 16.735 |
52 Week Low | 4.25 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.